MedTrace Logo

Analyzing the Relationship Between Speed Propofol is Given and Low Blood Pressure

NCT05415436 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-03-21

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the hemodynamic changes related to Propofol administration rate. We hypothesize that slow administration of IV propofol will have less hemodynamic disturbances and will require less amount of vasoactive medication for BP correction when compared to standard FDA approved administration rate.

Conditions

  • Hypotension on Induction

Interventions

OTHER

Propofol slow administration

Propofol will be slowly administered over 120 seconds by anesthesia provider

Sponsors & Collaborators

  • University of Toledo

    lead OTHER

Principal Investigators

  • Scott Pappada, PhD · University of Toledo

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-11
Primary Completion
2023-06-30
Completion
2023-07-21
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05415436 on ClinicalTrials.gov